How to Get Rapamycin (Sirolimus) in Texas

Texas Allows Telehealth Prescribing of Sirolimus

A Texas-licensed physician or qualified advanced practice provider can prescribe sirolimus after a synchronous telehealth visit that includes a medical history review and lab evaluation. The Texas Medical Board updated its telehealth rules under Senate Bill 1107 (2023), confirming that audio-video consultations satisfy the standard-of-care requirement for prescribing 1. No in-person visit is required before initiating therapy, provided the prescriber documents an adequate evaluation.

Several telehealth platforms now connect Texas patients with clinicians experienced in off-label rapamycin protocols. During the initial consultation, expect the prescriber to review your metabolic history, current medications, and contraindications. Rapamycin carries specific drug interactions with CYP3A4 inhibitors and inducers, and the prescriber must screen for concurrent use of medications like ketoconazole, rifampin, or calcineurin inhibitors 2. If your provider determines that weekly low-dose sirolimus is appropriate, they will transmit the prescription electronically to a pharmacy licensed in Texas.

Turnaround from consultation to medication receipt typically runs 5 to 10 business days: 1 to 3 days for the telehealth visit and lab review, plus 3 to 7 days for pharmacy compounding and shipping.

Who Can Prescribe Rapamycin in Texas

Texas law permits MDs, DOs, nurse practitioners, and physician assistants to prescribe sirolimus, with scope-of-practice distinctions that affect how the prescription originates. Physicians (MD/DO) hold independent prescriptive authority. NPs in Texas practice under a collaborative agreement with a physician, and PAs prescribe under a supervisory arrangement 3.

For off-label longevity prescribing, most patients work with physicians board-certified in internal medicine, endocrinology, or anti-aging medicine. The Endocrine Society's 2023 position statement on off-label prescribing acknowledges that physicians may use FDA-approved drugs for non-approved indications when supported by clinical evidence, provided they document the rationale 4.

A growing number of longevity-focused clinics in Austin, Dallas, Houston, and San Antonio now include rapamycin in their protocols. These practices often pair sirolimus with periodic mTOR pathway biomarker tracking and metabolic panel monitoring.

The Clinical Evidence Behind Off-Label Rapamycin

Rapamycin earned FDA approval in 1999 as an immunosuppressant for renal transplant recipients 2. Its mechanism of action, inhibition of the mechanistic target of rapamycin (mTOR), has since generated substantial interest in aging biology. mTOR is a nutrient-sensing kinase that regulates cell growth, autophagy, and senescence. Inhibiting mTOR with low-dose rapamycin appears to mimic caloric restriction at the cellular level 5.

The PEARL trial (Aging Cell, 2024; N=150) was among the first randomized, placebo-controlled studies to examine low-dose rapamycin in healthy older adults. Participants receiving 5 mg weekly for 12 months showed measurable improvements in age-related biomarkers, including a 7.4% reduction in visceral adipose tissue and improved insulin sensitivity compared with placebo 3. Adverse events were mild: mouth ulcers occurred in 12% of the rapamycin group versus 3% in placebo, and most resolved within two weeks of dose adjustment.

The Interventions Testing Program (ITP), funded by the National Institute on Aging, demonstrated that rapamycin extended median lifespan in genetically heterogeneous mice by 9% in males and 14% in females when started at 20 months of age (roughly equivalent to a 60-year-old human) 6. This was the first pharmacological intervention to extend lifespan in both sexes of a mammalian model. Dr. Matt Kaeberlein, a geroscience researcher formerly at the University of Washington, has noted: "Rapamycin remains the most reproducible pharmacological intervention for lifespan extension in laboratory animals."

These preclinical and early clinical results explain the growing demand among Texas patients seeking off-label access. The evidence is promising but not yet definitive for longevity endpoints in humans.

Required Labs Before Starting Sirolimus

Your prescriber will order baseline laboratory tests before writing a sirolimus prescription. These labs serve two purposes: screening for contraindications and establishing reference values for ongoing monitoring.

The standard baseline panel includes a complete blood count (CBC) with differential, comprehensive metabolic panel (CMP), fasting lipid panel, fasting glucose, and hemoglobin A1c 2. Sirolimus can cause dose-dependent hyperlipidemia and thrombocytopenia, so abnormal baseline lipids or low platelets may require dose modification or contraindicate use entirely. In the PEARL trial, total cholesterol increased by an average of 11 mg/dL in the rapamycin group over 12 months, with LDL rising by approximately 8 mg/dL 3.

Follow-up labs are typically drawn at 4 to 6 weeks after initiation, then every 3 to 6 months. A sirolimus trough level is not routinely measured in low-dose off-label protocols (unlike transplant dosing), but some clinicians check a trough at the 4-week mark to confirm the patient is in a low exposure range. For transplant patients, the FDA label recommends maintaining trough concentrations between 12 and 20 ng/mL during the first year; off-label longevity protocols typically aim for trough levels below 5 ng/mL, though no consensus guideline exists 7.

Texas patients can complete lab draws at any Quest, Labcorp, or independent phlebotomy location. Many telehealth platforms send a lab requisition order that patients can take to a draw site before the initial consultation.

503A Compounding Pharmacies in Texas

Texas licenses 503A compounding pharmacies under the Texas State Board of Pharmacy, which conducts routine inspections and enforces compliance with United States Pharmacopeia (USP) chapters 795 and 797 8. A 503A pharmacy compounds patient-specific prescriptions based on an individual order from a licensed prescriber. This distinction matters: 503A pharmacies cannot produce batch quantities for office stock without a patient-specific prescription.

Compounded sirolimus is available in oral capsule and liquid suspension formulations. Compounding allows for dose customization that commercial tablets do not offer. The standard Rapamune tablet comes in 0.5 mg, 1 mg, and 2 mg strengths. A 503A pharmacy can compound capsules in increments as small as 0.5 mg, allowing prescribers to fine-tune protocols to, say, 3 mg or 5 mg weekly doses without requiring patients to split or combine multiple commercial tablets.

Pricing through 503A pharmacies typically ranges from $30 to $90 per month depending on dose and formulation, compared with $200 to $800 per month for branded Rapamune or commercial generics without insurance. For Texas patients using rapamycin off-label (where insurance reimbursement is extremely unlikely), compounding represents significant cost savings.

Several 503A pharmacies in Houston, Dallas, and Austin ship statewide. Texas law permits a 503A pharmacy to ship compounded medications directly to the patient's home within state lines. Interstate shipping from a Texas 503A pharmacy requires compliance with the receiving state's regulations 8.

Texas Medicaid and Insurance Coverage

Texas Medicaid does not cover sirolimus for off-label longevity use. Coverage exists only for FDA-approved transplant rejection prevention, and even then, prior authorization is required 9. Commercial insurance plans in Texas similarly restrict coverage to on-label transplant indications.

For patients with transplant coverage, the prior authorization process typically requires the prescriber to submit documentation including the transplant date, organ type, current immunosuppressive regimen, and laboratory evidence of graft function. Turnaround for prior authorization in Texas averages 3 to 5 business days for standard requests and 24 to 72 hours for urgent requests.

The practical reality for longevity-use patients: plan to pay out of pocket. Compounded sirolimus through a 503A pharmacy remains the most affordable route. Some patients use manufacturer copay cards or GoodRx-type discount programs for commercial generic sirolimus, which can reduce the cash price to approximately $60 to $150 per month for a 1 mg daily supply (transplant dosing). Weekly low-dose protocols require fewer total milligrams, lowering the monthly cost further.

Safety Profile and Monitoring Schedule

Rapamycin's adverse effect profile at transplant doses (2 to 5 mg daily) is well characterized: hyperlipidemia, thrombocytopenia, oral mucositis, impaired wound healing, and increased infection susceptibility 2. At the lower doses used in longevity protocols (3 to 6 mg once weekly), the incidence and severity of these effects appear reduced, though long-term safety data from large randomized trials are still lacking.

In the PEARL trial, the most frequently reported adverse events in the rapamycin arm were aphthous ulcers (12%), mild elevations in total cholesterol (18%), and upper respiratory infections (8%) 3. No serious adverse events were attributed to rapamycin during the 12-month study period. A 2019 systematic review of mTOR inhibitor use in non-transplant populations (N=4,284 across 19 studies) found that the relative risk of serious infection was 1.07 (95% CI: 0.89 to 1.28), suggesting no statistically significant increase at low doses 7.

Your monitoring schedule should follow this pattern: labs at baseline, 4 to 6 weeks post-initiation, then every 3 to 6 months. Report any new mouth sores, unexplained bruising, or signs of infection to your prescriber immediately. Sirolimus should be discontinued at least 2 weeks before any planned surgery due to its effects on wound healing.

Step-by-Step Process for Texas Residents

Getting rapamycin in Texas follows a straightforward clinical pathway. Here is the sequence from start to finish.

Step 1: Choose a prescriber. Find a Texas-licensed MD, DO, NP, or PA experienced with sirolimus. Telehealth platforms specializing in longevity medicine are the fastest route for most patients.

Step 2: Complete baseline labs. Your prescriber will order a CBC, CMP, fasting lipid panel, fasting glucose, and HbA1c. Walk into any major lab network location in Texas with your requisition.

Step 3: Attend the consultation. During a 20 to 40 minute audio-video visit, your provider will review your labs, medical history, medications, and contraindications. If appropriate, they will prescribe sirolimus.

Step 4: Select a pharmacy. Your prescriber transmits the prescription to either a retail pharmacy (for commercial generic or brand) or a 503A compounding pharmacy. Compounded formulations cost less and allow precise dose customization.

Step 5: Receive and begin therapy. Compounded medications ship to your Texas address within 3 to 7 business days. Commercial pharmacy pickup is usually available within 1 to 3 days. Take your first dose according to your prescriber's instructions.

Step 6: Follow up. Schedule labs at 4 to 6 weeks. Your prescriber will review results and adjust dosing if needed.

According to the American Academy of Anti-Aging Medicine, clinicians prescribing off-label rapamycin should "maintain ongoing laboratory surveillance and document the clinical rationale at each visit" 10.

Transferring a Rapamycin Prescription to Texas

If you hold an active sirolimus prescription from another state, a Texas-licensed pharmacy can accept the transfer under Texas State Board of Pharmacy rules. The process requires your current pharmacy to communicate the prescription details (drug, dose, quantity, refills remaining, prescriber information) to the receiving Texas pharmacy. This communication can occur by phone, fax, or electronic transfer 8.

One exception: if your out-of-state prescription was written by a provider not licensed in Texas, you may need a Texas-licensed prescriber to issue a new prescription. Texas pharmacies can only fill prescriptions written by practitioners authorized to prescribe in the state. For patients relocating to Texas, the simplest path is scheduling a telehealth consultation with a Texas-licensed provider who can review your existing protocol and write a new prescription.